BR9206293A - Tiazolidinadionas hipoglicêmicas e intermediários - Google Patents

Tiazolidinadionas hipoglicêmicas e intermediários

Info

Publication number
BR9206293A
BR9206293A BR9206293A BR9206293A BR9206293A BR 9206293 A BR9206293 A BR 9206293A BR 9206293 A BR9206293 A BR 9206293A BR 9206293 A BR9206293 A BR 9206293A BR 9206293 A BR9206293 A BR 9206293A
Authority
BR
Brazil
Prior art keywords
intermediates
hypoglycemic thiazolidinediones
thiazolidinediones
hypoglycemic
Prior art date
Application number
BR9206293A
Other languages
English (en)
Portuguese (pt)
Inventor
David A Clark
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BR9206293A publication Critical patent/BR9206293A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
BR9206293A 1991-07-22 1992-07-01 Tiazolidinadionas hipoglicêmicas e intermediários BR9206293A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73377191A 1991-07-22 1991-07-22
PCT/US1992/005436 WO1993002079A1 (en) 1991-07-22 1992-07-01 Hypoglycemic thiazolidinediones and intermediates

Publications (1)

Publication Number Publication Date
BR9206293A true BR9206293A (pt) 1994-11-08

Family

ID=24949048

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9206293A BR9206293A (pt) 1991-07-22 1992-07-01 Tiazolidinadionas hipoglicêmicas e intermediários

Country Status (19)

Country Link
US (1) US6329408B1 (enExample)
EP (1) EP0641338A1 (enExample)
JP (1) JPH08823B2 (enExample)
CN (1) CN1030195C (enExample)
AU (1) AU665775B2 (enExample)
BR (1) BR9206293A (enExample)
CA (1) CA2111447C (enExample)
CZ (1) CZ282831B6 (enExample)
HU (1) HUT69692A (enExample)
IE (1) IE922357A1 (enExample)
IL (1) IL102573A (enExample)
MX (1) MX9204279A (enExample)
NO (1) NO301226B1 (enExample)
NZ (1) NZ243653A (enExample)
PT (1) PT100711B (enExample)
RU (1) RU2079497C1 (enExample)
TW (1) TW222626B (enExample)
WO (1) WO1993002079A1 (enExample)
ZA (1) ZA925468B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993002060A1 (en) * 1991-07-22 1993-02-04 Pfizer, Inc. Process for the preparation of intermediates in the synthesis of chiral thiazolidine-2,4-dione derivatives
GB9308487D0 (en) * 1993-04-23 1993-06-09 Smithkline Beecham Plc Novel compounds
PL337510A1 (en) 1997-06-18 2000-08-28 Smithkline Beecham Plc Treatment of diabetes by means of derivatives of thiazolydinone and sulphonylurea
SI1131070T1 (sl) * 1998-11-12 2008-12-31 Smithkline Beecham Plc Farmacevtski sestavek za modificirano sproĺ äśanje senzibilizatorja za inzulin in metformina
AR023700A1 (es) 1998-11-12 2002-09-04 Smithkline Beecham Plc Un procedimiento para preparar una composicion farmaceutica que comprende un sensibilizador de insulina
CA2370250C (en) * 1999-04-28 2009-12-29 Aventis Pharma Deutschland Gmbh Di-aryl acid derivatives as ppar receptor ligands
TW200514783A (en) * 1999-09-22 2005-05-01 Bristol Myers Squibb Co Substituted acid derivatives useful as antiodiabetic and antiobesity agents and method
PE20011021A1 (es) * 1999-11-10 2001-09-19 Takeda Pharmaceutical Compuestos heterociclicos de 5 miembros que contienen nitrogeno con actividad hipoglucemica e hipolipidemica
EP1295875A4 (en) * 2000-05-26 2004-05-06 Nippon Shinyaku Co Ltd HETEROCYCLIC COMPOUNDS
GB0014969D0 (en) 2000-06-19 2000-08-09 Smithkline Beecham Plc Novel method of treatment
JP2003040877A (ja) * 2001-07-24 2003-02-13 Sumika Fine Chemicals Co Ltd 5−[6−(2−フルオロベンジルオキシ)−2−ナフチル]メチル−2,4−チアゾリジンジオンの製造方法及びその精製方法
KR20050012771A (ko) * 2002-06-03 2005-02-02 노파르티스 아게 치환된 시아노피롤리딘의 용도 및 이들을 함유하는고지혈증 및 관련 질환의 치료를 위한 조합 제제
AU2003249879B2 (en) * 2002-07-03 2008-12-18 F. Hoffmann-La Roche Ag Oxazole derivatives and their use as insulin sensitizers
US8268352B2 (en) 2002-08-05 2012-09-18 Torrent Pharmaceuticals Limited Modified release composition for highly soluble drugs
US8216609B2 (en) 2002-08-05 2012-07-10 Torrent Pharmaceuticals Limited Modified release composition of highly soluble drugs
JP4661595B2 (ja) * 2003-09-22 2011-03-30 小野薬品工業株式会社 フェニル酢酸誘導体、その製造方法および用途
DE602004004631D1 (de) * 2004-04-01 2007-03-22 Sanofi Aventis Deutschland Oxadiazolone, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Pharmazeutika
US20120094959A1 (en) 2010-10-19 2012-04-19 Bonnie Blazer-Yost Treatment of cystic diseases
WO2016071727A1 (en) 2014-11-04 2016-05-12 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the prevention and the treatment of rapidly progressive glomerulonephritis
CN109867765A (zh) * 2019-02-28 2019-06-11 中山大学惠州研究院 一种长效缓释可降解防污聚氨酯及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
US4367234A (en) 1980-07-28 1983-01-04 Pfizer Inc. Hypoglycemic 5-substituted oxazolidine-2,4-diones
US4342771A (en) 1981-01-02 1982-08-03 Pfizer Inc. Hypoglycemic 5-substituted oxazolidine-2,4-diones
US4617312A (en) 1983-01-17 1986-10-14 Pfizer Inc. Aldose reductase inhibiting 5-(2-alkoxyphenyl) thiazolidinediones
CN1003445B (zh) 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物,其制备方法和用途
US4703052A (en) 1985-05-21 1987-10-27 Pfizer Inc. Hypoglycemic thiazolidinediones
FI91869C (fi) * 1987-03-18 1994-08-25 Tanabe Seiyaku Co Menetelmä antidiabeettisena aineena käytettävien bensoksatsolijohdannaisten valmistamiseksi
GB8713861D0 (en) * 1987-06-13 1987-07-15 Beecham Group Plc Compounds
WO1989008651A1 (en) * 1988-03-08 1989-09-21 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
US5036079A (en) 1989-12-07 1991-07-30 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
US5089514A (en) 1990-06-14 1992-02-18 Pfizer Inc. 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents

Also Published As

Publication number Publication date
JPH07502487A (ja) 1995-03-16
NO940225L (no) 1994-01-21
NZ243653A (en) 1995-02-24
TW222626B (enExample) 1994-04-21
IL102573A0 (en) 1993-01-14
CN1030195C (zh) 1995-11-01
CZ282831B6 (cs) 1997-10-15
IL102573A (en) 1997-04-15
RU2079497C1 (ru) 1997-05-20
HUT69692A (en) 1995-09-28
CZ12494A3 (en) 1994-07-13
MX9204279A (es) 1994-03-31
JPH08823B2 (ja) 1996-01-10
IE922357A1 (en) 1993-01-27
WO1993002079A1 (en) 1993-02-04
CA2111447A1 (en) 1993-02-04
ZA925468B (en) 1994-01-21
EP0641338A1 (en) 1995-03-08
AU2297392A (en) 1993-02-23
HU9400181D0 (en) 1994-05-30
CN1068823A (zh) 1993-02-10
PT100711A (pt) 1993-09-30
NO940225D0 (no) 1994-01-21
NO301226B1 (no) 1997-09-29
US6329408B1 (en) 2001-12-11
PT100711B (pt) 1999-07-30
CA2111447C (en) 2002-08-13
AU665775B2 (en) 1996-01-18

Similar Documents

Publication Publication Date Title
BR9206293A (pt) Tiazolidinadionas hipoglicêmicas e intermediários
FI20001900A7 (fi) Välituotteet
FI930605L (fi) Cd40cr-receptor och ligander foer denna
FI930064A7 (fi) Anpassningsbar ekvalisator och mottagare
FI931183A0 (fi) Halvledarkondensator och mikrofonanordning
FI931085A0 (fi) Antitumoerkompositioner och behandlingsmetoder
FI924060A7 (fi) Cellulaert radionaet och mobilradiostation
DE69301495D1 (de) Wegwerfeinsatz
FI930076L (fi) Cysteamin innehaollande permanentningskomposition och foerfarande
FI930831A7 (fi) Kelatkomplex och foerfarande foer deras framstaellning
FI930457L (fi) Stabilt vaordschampo innehaollande katjoniska och suspenderade vattenoloesliga vaordmedel
FI922004L (fi) Maetningsfoerfarande och maetanordning
FI930104A7 (fi) Verktyg foer slagborrning och meissling och verktygshaollare foer saodana verktyg
FI930777A7 (fi) Foeraedling och foerfarande foer avfallspapper
FI930453L (fi) Tumoerhaemmande kompositioner och behandlingsmetoder
FI931346L (fi) Butadienderivat och foerfarande foer deras framstaellning
FI925364L (fi) Foerfarande och anordning foer traodloes informationsoeverfoering
FI933376A0 (fi) 4-amino-3-acylkinolinderivater och deras anvaendning som inhibitorer avmagsyrasekretion
BR9205281A (pt) Pentapeptideos imuno-reguladores e neuro-reguladores
FI930180A7 (fi) X-paket-maongkomponentenkoder och motsvarande dekoder
FI940308A7 (fi) Hypoglykeemiset tiatsolidiinidionit ja välituotteet
NO924553L (no) Avstembar mikroboelgeoscillator
SE9302321D0 (sv) Laasbar gaeng och stiftbult
FI970043A0 (fi) Aryylialkyylipiperidiini välituotteet
SE9202418D0 (sv) Djur och faarstaengsel

Legal Events

Date Code Title Description
EE Request for examination
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
FC Decision: refusal